Success Metrics

Clinical Success Rate
99.2%

Based on 130 completed trials

Completion Rate
99%(130/131)
Active Trials
3(2%)
Results Posted
49%(64 trials)
Terminated
1(1%)

Phase Distribution

Ph early_phase_1
1
1%
Ph phase_1
46
34%
Ph not_applicable
1
1%
Ph phase_3
53
39%
Ph phase_4
11
8%
Ph phase_2
11
8%

Phase Distribution

47

Early Stage

11

Mid Stage

64

Late Stage

Phase Distribution123 total trials
Early Phase 1First-in-human
1(0.8%)
Phase 1Safety & dosage
46(37.4%)
Phase 2Efficacy & side effects
11(8.9%)
Phase 3Large-scale testing
53(43.1%)
Phase 4Post-market surveillance
11(8.9%)
N/ANon-phased studies
1(0.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

99.2%

130 of 131 finished

Non-Completion Rate

0.8%

1 ended early

Currently Active

3

trials recruiting

Total Trials

135

all time

Status Distribution
Active(3)
Completed(130)
Terminated(1)
Other(1)

Detailed Status

Completed130
Active, not recruiting2
Recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
135
Active
3
Success Rate
99.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.8%)
Phase 146 (37.4%)
Phase 211 (8.9%)
Phase 353 (43.1%)
Phase 411 (8.9%)
N/A1 (0.8%)

Trials by Status

recruiting11%
active_not_recruiting21%
completed13096%
unknown11%
terminated11%

Recent Activity

Clinical Trials (135)

Showing 20 of 135 trialsScroll for more
NCT06685185Phase 1

A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes

Completed
NCT06280703Phase 1

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Recruiting
NCT06153537

A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level

Completed
NCT05069545

A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice

Completed
NCT04770532Phase 3

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin

Completed
NCT04848480Phase 3

A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)

Completed
NCT04588259Phase 3

Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

Completed
NCT06767748Phase 3

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

Active Not Recruiting
NCT07018453Phase 2

A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

Active Not Recruiting
NCT04760626Phase 3

A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

Completed
NCT05463744Phase 3

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Completed
NCT05275400Phase 3

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Completed
NCT06288412Phase 1

A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

Completed
NCT05362058Phase 3

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

Completed
NCT05243628Phase 4

Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes

Completed
NCT04538352Phase 4

Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

Completed
NCT06202079Phase 2

A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus

Completed
NCT04795531Phase 3

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Completed
NCT05218915Phase 4

Basal Plus GLP1-ra on Glycemic Variability in CKD

Completed
NCT06556641Phase 1

A Clinical Study of GZR33 and GZR101 in Healthy Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
135